Comparison of Two Different Treatment Methods

December 19, 2022 updated by: Banu BAYAR

Comparison of Short-term Effects of Two Different Treatment Methods in Patients With Subacromial Impingement Syndrome: a Randomized Controlled Single-blind Trial

A number of previous studies investigated the effects of kinesiotaping (KT) in subacromial impingement syndrome (SIS).

Study Overview

Detailed Description

Subacromial impingement syndrome (SIS) is characterized by shoulder pain that is exacerbated with especially arm elevation or overhead physical activities.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Muğla, Turkey, 48000
        • Muğla Sıtkı Kocman University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

31 years to 61 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Impingement symptoms in clinical tests
  • Pain >1 month

Exclusion Criteria:

  • Any shoulder pathology.
  • Have chronic systemic diseases or infections.
  • History of any surgery shoulder complex.
  • steroid injections and therapeutic approaches

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group (CG)
Control group
Experimental: Kinesiotaping Group (KG)
Experimental group
KT was applied.
Experimental: Mulligan Mobilization Technique Group (MG)
Experimental group (2)
MMT was applied

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of pain severity
Time Frame: Baseline- after 2 weeks (after treatment)
Via VAS.
Baseline- after 2 weeks (after treatment)
Change of Range of Motion
Time Frame: Baseline- after 2 weeks (after treatment)
Via goniometer.
Baseline- after 2 weeks (after treatment)
Change of Functionality
Time Frame: Baseline- after 2 weeks (after treatment)
Via SPADI.
Baseline- after 2 weeks (after treatment)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Sleep Quality
Time Frame: Baseline- after 2 weeks (after treatment)
Via VAS.
Baseline- after 2 weeks (after treatment)
Change of Satisfaction of Life
Time Frame: Baseline- after 2 weeks (after treatment)
Via SWLS.
Baseline- after 2 weeks (after treatment)
Change of Satisfaction of Treatment
Time Frame: Baseline- after 2 weeks (after treatment)
Via VAs.
Baseline- after 2 weeks (after treatment)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 28, 2021

Primary Completion (Actual)

October 15, 2021

Study Completion (Actual)

November 30, 2021

Study Registration Dates

First Submitted

September 28, 2021

First Submitted That Met QC Criteria

September 28, 2021

First Posted (Actual)

October 8, 2021

Study Record Updates

Last Update Posted (Actual)

December 21, 2022

Last Update Submitted That Met QC Criteria

December 19, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Diseases

Clinical Trials on Kinesiotaping

Subscribe